Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 524
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03844360 | Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease | ||
| NCT07307443 | A Phase II Study of Anlotinib and Platinum-Based Chemotherapy in Patients With SMARCA4-Deficient, Locally Advanced or Metastatic Lung Cancer. | ||
| NCT06544668 | A Study for Dynamic Prediction Model of Breast Cancer Bone Metastases | ||
| NCT06136026 | Integrated Chinese and Western Medicine Specialized Disease Cohort for Colorectal Cancer | ||
| NCT07164872 | Neoadjuvant Chemotherapy Combined With Preoperative Radiotherapy for Locally Advanced Breast Cancer | ||
| NCT05050630 | Phase II Trial of Tirelizumab Combined With R2-ICE Regimen in the Treatment of rrDLBCL/HGBL | ||
| NCT06592092 | Clinical Study of QH104 Cell Injection for the Treatment of Meningeal Metastases of B7H3+ Solid Tumors | ||
| NCT03874871 | Function Preserving Gastrectomy for T1/2 Gastric Cancer Patients | ||
| NCT05188859 | First Line Sintilimab Combined With Anlotinib and Platinum Doublet Chemotherapy in Malignant Pleural Mesothelioma | ||
| NCT07037680 | Radiotherapy Plus Anlotinib in LA-NSCLC Intolerable to cCRT | ||
| NCT04500704 | Almonertinib Plus Chemotherapy as First-line Treatment in Patients With EGFR Concomitant Non-EGFR Driver Gene Mutant, Locally Advanced or Metastatic NSCLC | ||
| NCT04339660 | Clinical Research of Human Mesenchymal Stem Cells in the Treatment of COVID-19 Pneumonia | ||
| NCT07443397 | Anlotinib Plus Whole-Brain Radiotherapy for Brain Metastases in SCLC Patients. | ||
| NCT04500717 | Almonertinib Plus Chemotherapy as First-line Treatment in Patients With EGFR Concomitant Tumor Suppressor Gene Mutation | ||
| NCT03575806 | Combine TACE and Autologous Tcm Immunotherapy Versus TACE Alone for HCC With MVI After Radical Resection | ||
| NCT07454941 | Artificial Intelligence-assisted HER2 Expression Assessment in Urothelial Carcinoma Based on Imaging-pathology Omics | ||
| NCT06408623 | Chidamide Combined With Sintilimab and Bevacizumab for the First-line Treatment of Advanced Liver Cancer | ||
| NCT07204041 | Efficacy and Safety of XTD Regimen (Selinexor, Thalidomide and Dexamethasone) in Adult Patients With Relapsed/Refractory LCH | ||
| NCT01024712 | Paclitaxel, Carboplatin, and Gefitinib in Treating Patients With Advanced Non-Small Cell Lung Cancer | ||
| NCT04821843 | Neoadjuvant Treatment Modalities in Esophageal Cancer | ||
| NCT06287320 | The Predictive Biomarkers in Patients With Locally Advanced Non-small Cell Lung Cancer | ||
| NCT06289023 | HA-WBRT-SIB for Brain Metastasis of Lung Cancer | ||
| NCT04320979 | Postmastecomy Internal Mammary Nodal Irradiation for High-risk Breast Cancer Patients | ||
| NCT07440901 | Remodeling of MHC-related Immune Microenvironment in MIBC After Neoadjuvant Therapy | ||
| NCT06255912 | Clinical Trial for Advanced or Metastatic Pancreatic Cancer | ||
| NCT02815007 | Chidamide With EGFR-TKI for Advanced EGFR-TKI-resistant Non-Small Cell Lung Cancer | ||
| NCT07141771 | An Umbrella Study of Recurrent, Extensive Stage Small Cell Lung Cancer Based on Molecular Typing | ||
| NCT07307053 | Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2) | ||
| NCT06078930 | Development of Novel Gastric Cancer Screening and Diagnosis Technologies Using Tongue Imaging and Study of Tongue Image Changes Mechanisms | ||
| NCT04213937 | Nab-paclitaxel Versus Topotecan As Second-Line Treatment for Patients With Extensive Stage Small Cell Lung Cancer | ||
| NCT01918241 | Saftey and Efficacy of Pegfilgrastim in Preventing Chrmotherapy-induced Neutropenia | ||
| NCT06196554 | Gastric Cancer Organoids in the Screening of Neoadjuvant Drugs | ||
| NCT07461727 | An Open-Label, Single-Arm, Dose-Escalation Phase I Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of EDB-102 in Patients With EGFR L858R-Mutant, Third-Generation TKI-Resistant Advanced Non-Small Cell Lung Cancer With Liver Metastases | ||
| NCT03511170 | XELOX and XELIRI Alternative Regimen as First-line Treatment for Advanced Colorectal Cancer | ||
| NCT07480837 | Dynamic Monitoring of Plasma ctDNA for Prognostic Assessment in Patients With B-Cell Non-Hodgkin Lymphoma | ||
| NCT07366658 | Safety, Tolerability and Preliminary Efficacy of NEUK203-13 in Refractory Neuroendocrine Tumor Patients | ||
| NCT06345287 | Response Adaptive Radiotherapy Following Immunotherapy-based Induction for Non-HPV Related HNSCC | ||
| NCT02883374 | Chidamide for Advanced Cephalic and Cervical Adenocystic Carcinoma: Evaluation of Efficiency and Safety | ||
| NCT04042597 | Anlotinib Hydrochloride Versus Imatinib Mesylate in Locally Advanced, Unresectable or Metastatic Chordoma | ||
| NCT05777824 | Postoperative Management for HNSCC Based on Pathological Response of Induction Chemotherapy and Immunotherapy | ||
| NCT05411705 | Efficacy and Safety of rhTPO's Prophylactic Treatment of CTIT in Patients With High Risk of Cardiac Injury | ||
| NCT07380230 | Efficacy and Safety of Qibei Jiedu Formula for Preventing and Managing Acute Radiation Dermatitis in Breast Cancer Patients | ||
| NCT02688023 | Neoadjuvant Triplet Chemotherapy Regimen in Patients With Resectable Colorectal Cancer | ||
| NCT04879654 | Toripalimab Combined With Radiotherapy and Chemotherapy in the Treatment of SNMM After Endoscopic Surgery | ||
| NCT02765620 | PERCIST Criteria for Response Evaluation With Solid Tumors | ||
| NCT07383246 | CTR-FAPI-guided Precision Surgery for Newly Diagnosed MTC | ||
| NCT07166003 | Efficacy of Neoadjuvant Immunotherapy in Patients With Lung Cancer | ||
| NCT05747313 | Chidamide in Combination With Vincristine Metronomic Chemotherapy for Advanced Triple-negative Breast Cancer | ||
| NCT06655285 | The Impact of Inflammatory Adhesion on the Prognosis of Colon Cancer Patients | ||
| NCT07352280 | Neoadjuvant Therapy With Tislelizumab for dMMR/MSI-H Stage II-III Colorectal Cancer |
